Intrinsic Value of S&P & Nasdaq Contact Us

Biotricity, Inc. BTCY OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
46/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+1381.9%

Biotricity, Inc. (BTCY) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Redwood City, CA, United States. The current CEO is Waqaas Al-Siddiq.

BTCY has IPO date of 2018-02-16, 55 full-time employees, listed on the Other OTC, a market capitalization of $7.68M.

About Biotricity, Inc.

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

📍 275 Shoreline Drive, Redwood City, CA 94065 📞 650 832 1626
Company Details
SectorHealthcare
IndustryMedical - Devices
CountryUnited States
ExchangeOther OTC
CurrencyUSD
IPO Date2018-02-16
CEOWaqaas Al-Siddiq
Employees55
Trading Info
Current Price$0.27
Market Cap$7.68M
52-Week Range0.2-0.7536
Beta1.40
ETFNo
ADRNo
CUSIP09074H104
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message